Senior insider sale
Chief Scientific Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$112.2K
14.16K shares
What this filing means
HEIER JEFFREY S. plans to sell 14.16K shares of OCULAR THERAPEUTIX, INC valued at approximately $112.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/2/2026ACC: 0001950047-26-009997
Officer· Chief Scientific Officer
Since Feb 2026
14.16K
Shares to sell
$112.2K
Approx. market value
10.87K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Not Applicable
10/1/2026
10.87KTotal acquired10.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2026 | Restricted Stock Vesting Under a Registered Plan Not Applicable | 10.87K | — |
| Total | 10.87K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.30K
Market value
$35.5K
8/24/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.87K
Market value
$76.6K
10/2/2026
Total
Units
14.16K
Value
$112.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/24/2026 | 3.30K | $35.5K | — | Completed |
| Planned — Approximate Date | ||||
10/2/2026 | 10.87K | $76.6K | NASDAQ | Planned |
| Total | 14.16K | $112.2K | ||